Management of Primary Eyelid Cancers

  • Aaron SavarEmail author
  • Bita Esmaeli
Part of the M.D. Anderson Solid Tumor Oncology Series book series (MDA, volume 6)


A number of different cancers can affect the eyelid. Basal cell carcinoma is the most common; squamous cell carcinoma, melanoma, and sebaceous cell carcinoma are less common. Management of these tumors is most commonly surgical, although chemotherapy and radiation therapy play a role in some cases. Complex tumors require a multidisciplinary approach and long-term follow-up.


Sentinel Lymph Node Sentinel Lymph Node Biopsy Basal Cell Carcinoma Merkel Cell Carcinoma Actinic Keratose 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Cook BE Jr, Bartley GB. Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota. Ophthalmology 1999;106:746–50.PubMedCrossRefGoogle Scholar
  2. 2.
    Snow SN, Sahl W, Lo JS, et al. Metastatic basal cell carcinoma. Report of five cases. Cancer 1994;73:328–35.PubMedCrossRefGoogle Scholar
  3. 3.
    Limawararut V, Leibovitch I, Sullivan T, et al. Periocular squamous cell carcinoma. Clin Exp Ophthalmol 2007;35:174–85.CrossRefGoogle Scholar
  4. 4.
    Faustina M, Diba R, Ahmadi MA, et al. Patterns of regional and distant metastasis in patients with eyelid and periocular squamous cell carcinoma. Ophthalmology 2004;111:1930–2.PubMedCrossRefGoogle Scholar
  5. 5.
    Esmaeli B, Wang B, Deavers M, et al. Prognostic factors for survival in malignant melanoma of the eyelid skin. Ophthal Plast Reconstr Surg 2000;16:250–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Shields JA, Demirci H, Marr BP, et al. Sebaceous carcinoma of the eyelids: personal experience with 60 cases. Ophthalmology 2004;111:2151–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Song A, Carter KD, Syed NA, et al. Sebaceous cell carcinoma of the ocular adnexa: clinical presentations, histopathology, and outcomes. Ophthal Plast Reconstr Surg 2008;24:194–200.PubMedCrossRefGoogle Scholar
  8. 8.
    Durairaj VD, Hink EM, Kahook MY, et al. Mucinous eccrine adenocarcinoma of the periocular region. Ophthal Plast Reconstr Surg 2006;22:30–5.PubMedCrossRefGoogle Scholar
  9. 9.
    Mehta S, Thiagalingam S, Zembowicz A, et al. Endocrine mucin-producing sweat gland carcinoma of the eyelid. Ophthal Plast Reconstr Surg 2008;24:164–5.PubMedCrossRefGoogle Scholar
  10. 10.
    Aurora AL, Luxenberg MN. Case report of adenocarcinoma of glands of Moll. Am J Ophthalmol 1970;70:984–90.PubMedGoogle Scholar
  11. 11.
    Seregard S. Apocrine adenocarcinoma arising in Moll gland cystadenoma. Ophthalmology 1993;100:1716–9.PubMedGoogle Scholar
  12. 12.
    Barker-Griffith AE, Streeten BW, Charles NC. Moll gland neoplasms of the eyelid: a clinical and pathological spectrum in 5 cases. Arch Ophthalmol 2006;124:1645–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Marback EF, Costa AL, Nossa LM, et al. Eyelid skin adenoid cystic carcinoma: a clinicopathological study of one case simulating sebaceous gland carcinoma. Br J Ophthalmol 2003;87:118–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Jakobiec FA. Ocular adnexal lymphoid tumors: progress in need of clarification. Am J Ophthalmol 2008;145:941–50.PubMedCrossRefGoogle Scholar
  15. 15.
    Margo CE, Mulla ZD. Malignant tumors of the eyelid: a population-based study of non-basal cell and non-squamous cell malignant neoplasms. Arch Ophthalmol 1998;116:195–8.PubMedGoogle Scholar
  16. 16.
    Conway RM, Hammer T, Viestenz A, et al. Cutaneous angiosarcoma of the eyelids. Br J Ophthalmol 2003;87:514–5.PubMedCrossRefGoogle Scholar
  17. 17.
    Eng TY, Boersma MG, Fuller CD, et al. A comprehensive review of the treatment of Merkel cell carcinoma. Am J Clin Oncol 2007;30:624–36.PubMedCrossRefGoogle Scholar
  18. 18.
    Missotten GS, de Wolff-Rouendaal D, de Keizer RJ. Merkel cell carcinoma of the eyelid review of the literature and report of patients with Merkel cell carcinoma showing spontaneous regression. Ophthalmology 2008;115:195–201.PubMedCrossRefGoogle Scholar
  19. 19.
    Feng H, Shuda M, Chang Y, et al. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008;319:1096–100.PubMedCrossRefGoogle Scholar
  20. 20.
    Ainbinder DJ, Esmaeli B, Groo SC, et al. Introduction of the 7th edition eyelid carcinoma classification system from the American Joint Committee on Cancer–International Union Against Cancer staging manual. Arch Pathol Lab Med 2009;133(8):1256–61.PubMedGoogle Scholar
  21. 21.
    Nemet AY, Deckel Y, Martin PA, et al. Management of periocular basal and squamous cell carcinoma: a series of 485 cases. Am J Ophthalmol 2006;142:293–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Malhotra R, Huilgol SC, Huynh NT, et al. The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up. Ophthalmology 2004;111:631–6.PubMedCrossRefGoogle Scholar
  23. 23.
    Günalp I, Gündüz K, Dürük K. Orbital exenteration: a review of 429 cases. Int Ophthalmol 1995–1996;19:177–84.CrossRefGoogle Scholar
  24. 24.
    Tyers AG. Orbital exenteration for invasive skin tumours. Eye 2006;20:1165–70.PubMedCrossRefGoogle Scholar
  25. 25.
    deSousa JL, Leibovitch I, Malhotra R, et al. Techniques and outcomes of total upper and lower eyelid reconstruction. Arch Ophthalmol 2007;125:1601–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Esmaeli B. Sentinel node biopsy as a tool for accurate staging of eyelid and conjunctival malignancies. Curr Opin Ophthalmol 2002;13:317–23.PubMedCrossRefGoogle Scholar
  27. 27.
    Nijhawan N, Ross MI, Diba R, et al. Experience with sentinel lymph node biopsy for eyelid and conjunctival malignancies at a cancer center. Ophthal Plast Reconstr Surg 2004;20:291–5.PubMedCrossRefGoogle Scholar
  28. 28.
    Ho VH, Ross MI, Prieto VG, et al. Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa. Arch Otolaryngol Head Neck Surg 2007;133:820–6.PubMedCrossRefGoogle Scholar
  29. 29.
    Savar A, Ross MI, Prieto VG, Ivan D, Kim SK, Esmaeli B. Sentinel lymph node biopsy for ocular adnexal melanoma: experience in 30 patients. Ophthalmology 2009;116(11):2217–23.PubMedCrossRefGoogle Scholar
  30. 30.
    Geisse J, Caro I, Lindholm J, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 2004;50:722–33.PubMedCrossRefGoogle Scholar
  31. 31.
    Choontanom R, Thanos S, Busse H, et al. Treatment of basal cell carcinoma of the eyelids with 5% topical imiquimod: a 3-year follow-up study. Graefes Arch Clin Exp Ophthalmol 2007;245:1217–20.PubMedCrossRefGoogle Scholar
  32. 32.
    Brannan PA, Anderson HK, Kersten RC, et al. Bowen disease of the eyelid successfully treated with imiquimod. Ophthal Plast Reconstr Surg 2005;21:321–2.PubMedCrossRefGoogle Scholar
  33. 33.
    Murchison AP, Washington CV, Soloman AR, et al. Ocular effects of imiquimod with treatment of eyelid melanoma in situ. Dermatol Surg 2007;33:1136–8.PubMedCrossRefGoogle Scholar
  34. 34.
    Carucci JA, Leffell DJ. Intralesional interferon alfa for treatment of recurrent lentigo maligna of the eyelid in a patient with primary acquired melanosis. Arch Dermatol 2000;136:1415–6.PubMedCrossRefGoogle Scholar
  35. 35.
    Shields CL, Naseripour M, Shields JA, et al. Topical mitomycin-C for pagetoid invasion of the conjunctiva by eyelid sebaceous gland carcinoma. Ophthalmology 2002;109:2129–33.PubMedCrossRefGoogle Scholar
  36. 36.
    Bianchi L, Orlandi A, Campione E, et al. Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases. Br J Dermatol 2004;151:148–56.PubMedCrossRefGoogle Scholar
  37. 37.
    Shields JA, De Potter P, Shields CL, et al. Kaposi’s sarcoma of the eyelids: response to radiotherapy. Arch Ophthalmol 1992;110:1689.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Section of Ophthalmology, Department of Head and Neck SurgeryThe University of Texas M.D. Anderson Cancer CenterHoustonUSA

Personalised recommendations